Related Experiment Video
Updated: Jun 5, 2025
06:15
Author Spotlight: Anterior HR-OCT as a Non-Invasive Tool for Characterizing Ocular Surface Squamous Neoplasia
Published on: August 9, 2024
1.1K
Malignant struma ovarii in pregnancy: A case report
Raveena Kapoor1, Monalisa Sur2, Julie M V Nguyen3
1Department of Medicine, University of British Columbia, 2775 Laurel Street, Vancouver, British Columbia V5Z 1M9, Canada.
Gynecologic Oncology Reports
|December 4, 2024
Summary
Malignant struma ovarii (MSO) in pregnancy is rare. This case highlights individualized, fertility-sparing management and discusses the debated roles of thyroidectomy and radioactive iodine therapy for MSO.
Area of Science:
- Gynecologic Oncology
- Reproductive Endocrinology
- Endocrinology
Background:
- Struma ovarii, predominantly thyroid tissue ovarian tumors, are rare, comprising <1% of ovarian neoplasms.
- Malignant struma ovarii (MSO) is exceptionally rare, accounting for ~5% of struma ovarii, with limited evidence guiding management.
- The management of MSO during pregnancy presents unique challenges due to rarity and potential impact on maternal-fetal outcomes.
More Related Videos
Related Concept Videos
01:24Disorders of the Female Reproductive System
323
The female reproductive system can be affected by several disorders, including Premenstrual Syndrome (PMS), Premenstrual Dysphoric Disorder (PMDD), endometriosis, and various forms of cancer. PMS and PMDD are cyclical conditions that cause physical and emotional distress, with symptoms that include edema, mood swings, and food cravings. PMDD is a more severe form of PMS characterized by increased symptom severity that peaks during the luteal phase and tends to improve or resolve shortly after...
323
01:27Ovarian Cycle
1.0K
The menstrual cycle includes a critical component known as the ovarian cycle, which undergoes two main phases each month—the follicular phase and the luteal phase. The follicular phase is variable and averaging around 14 days. Ovulation, triggered by a surge in luteinizing hormone (LH), marks the transition between the two phases. The second phase, the luteal phase, is relatively consistent, lasting approximately 14 days, and is marked by the activity of the corpus luteum. While a cycle...
1.0K